Taiwan FDA registration fc33844176cb2ba9af20473319ca39fd
"Trinity Biotechnology" red blood cell hemolytic agent (unsterilized)
TW: “崔尼蒂生技”紅血球溶血劑(未滅菌)
Taiwan·Risk Class 1·TRINITY BIOTECH·Registered Jan 20, 2012 – Jan 20, 2022CancelledRegistration details
- Analysis ID
- fc33844176cb2ba9af20473319ca39fd
- Customs Code
- DHA04401131809
Company information
- Manufacturer
- TRINITY BIOTECH
- Manufacturer Country
- Ireland
- Authorized Representative
- BioChain Co., Ltd.
Product details
- Intended Use
- Limited to the first level identification range of red blood cell dissolving agent (B.8540) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.8540 紅血球溶解劑
- Import Information
- import
Dates and status
- Registration Date
- Jan 20, 2012
- Expiry Date
- Jan 20, 2022
- Cancellation Date
- May 23, 2023
Cancellation information
- Status
- Logged out
- Reason
- 屆期未申請展延
About this record
Access comprehensive regulatory information for "Trinity Biotechnology" red blood cell hemolytic agent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number fc33844176cb2ba9af20473319ca39fd and manufactured by TRINITY BIOTECH. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices